Daniel Lau
Psychiatric/Mental Health · Toledo, OHNPI 1225587090
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 317 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,071 and has fallen 73.3% since, to $554 in 2025. Among psychiatric/mental health clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 317 payments — averaging $19.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- AbbVie$1K
- Indivior Inc.$831
- Otsuka America Pharmaceutical, Inc.$670
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$429
- Teva Pharmaceuticals USA, Inc.$353
- plus $2K from 16 others
What the payments were for
- Food & beverage$6,21399%
- Education$751%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 44 | $1,139 |
| AbbVie(2 entities) | 36 | $1,031 |
| Indivior Inc. | 76 | $831 |
| Otsuka America Pharmaceutical, Inc. | 40 | $670 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $429 |
| Teva Pharmaceuticals USA, Inc. | 19 | $353 |
| Axsome Therapeutics, Inc. | 13 | $315 |
| Johnson & Johnson | 9 | $239 |
| Braeburn Inc. | 2 | $234 |
| Sunovion Pharmaceuticals Inc. | 10 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $152 |
| Lundbeck LLC | 8 | $151 |
| Avanir Pharmaceuticals, Inc. | 6 | $112 |
| Neurocrine Biosciences, Inc. | 6 | $104 |
| Eisai Inc. | 2 | $103 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Almatica Pharma LLC | 2 | $52 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| Bausch Health US, LLC | 2 | $33 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Corium, LLC | 2 | $22 |
| Noven Therapeutics, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$965
- ARISTADA$480
- BRIXADI$234
- INVEGA SUSTENNA$125
- INVEGA TRINZA$125
- INVEGA$125
- SPRAVATO$125
- VRAYLAR$125
- ARISTADA INITIO$120
How this compares
$6,289 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $11,882 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $750 |
| Atorvastatin Calcium | 18 | $217 |
| Amlodipine Besylate | 22 | $161 |
| Levothyroxine Sodium | 13 | $127 |
| Omeprazole | 15 | $97 |
| Donepezil Hcl | 14 | $93 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Toledo
- Christine MillerToledo$12K
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.